vaccine development

Pharma

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Several other pharma companies have signed material transfer agreements so that they can experiment with Novavax's Matrix-M before committing to a deal.

Angus Liu Apr 6, 2026 8:37am

settlement lawsuit litigation cash settlement gavel

Moderna commits $950M upfront to resolve patent lawsuit

Mar 4, 2026 10:33am

Bavarian Nordic's longtime CEO Paul Chaplin to depart

Mar 2, 2026 10:23am

Horseshoe magnet attracting metallic pawn people

Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase

Dec 29, 2025 10:24am

12 former FDA chiefs blast Prasad's vaccine policy shake-ups

Dec 4, 2025 10:36am

Moderna outlines 3-year business strategy in bid to break even

Nov 20, 2025 2:54pm